Mark Whitaker;Trevor Charles Roche;Osama Ahmed Aswania;Zhong Jiang
发明人:
Osama Ahmed Aswania,Zhong Jiang,Trevor Charles Roche,Mark Whitaker
申请号：
US13819149
公开号：
US20130156828A1
申请日:
2011.08.31
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A drug product comprises a dry powder inhalation device having a pharmaceutical composition present therein, said pharmaceutical composition comprising a compound which is (6α, 11β, 16α, 17α)-6,9-difluoro-17-{[(fluoromethyl)thio]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1, 4-dien-17-yl 2-furancarboxylate or a solvate thereof； a hygroscopic material, and a package which encompasses the dry powder inhalation device and the hygroscopic material defining an enclosed volume therein, wherein the enclosed volume exhitbits a Relative Humidity of from 20% to 40%.
